RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $244

Benzinga · 3d ago
RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE:RMD) with a Sector Perform and raises the price target from $234 to $244.